Keyphrases
Pharmacokinetic Interaction
100%
Antiparasitic Agents
100%
Spinosad
100%
Ivermectin
100%
P-glycoprotein (P-gp)
28%
Treatment Group
21%
Efflux
14%
IC50
14%
Pharmacokinetics
7%
High Affinity
7%
Blood-brain Barrier
7%
Area under the Curve
7%
High Dose
7%
Systemic Medications
7%
Madin-Darby Canine Kidney (MDCK) Cells
7%
Drug Transporters
7%
Multidrug Resistance Protein 1 (MDR1)
7%
Neurotoxicity
7%
ATP-binding Cassette Transporter A1 (ABCA1)
7%
Secretory Pathway
7%
Digoxin
7%
Plasma Pharmacokinetics
7%
Drug Levels
7%
Neurological Effects
7%
Fleas
7%
Acetoxymethyl Ester
7%
Beagle Dog
7%
Heartworm Prevention
7%
Transwell
7%
P-glycoprotein Transporter
7%
P-glycoprotein Inhibitor
7%
Calcein
7%
Pharmacology, Toxicology and Pharmaceutical Science
Antiparasitic Agent
100%
Spinosad
100%
Ivermectin
100%
Pharmacokinetics
100%
P-Glycoprotein
35%
Treatment Group
21%
Effusion
14%
IC50
14%
Adenosine Triphosphate
7%
Side Effect
7%
Neurotoxicity
7%
Digoxin
7%
Beagle
7%
Glycoprotein P Inhibitor
7%
Calcein
7%
Dirofilaria immitis
7%
Blood-Brain Barrier
7%
Multidrug Resistance
7%